LineaGen Raises Round

LineaGen Inc., a Salt Lake City, Utah-based biomarker discovery company, has announced its launch with the close of a $5.8-million funding round led by Sanderling Biomedical Ventures and vSpring Capital. Mesa Verde Venture Partners was the third strategic investment partner in the Series A round. LineaGen has named Dinesh Patel of vSpring, Fred Middleton of Sanderling and Dan Wood of Mesa Verde to the company's board of directors. www.LineaGen.com